Почетна › Рак на простата › Округ Колумбија › Washington
Клинички испитувања за Рак на простата во Washington, DC
38 студии за Рак на простата бараат учесници на локации во и околу Washington (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.
Официјален текст на студијата (англиски)
Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Се регрутираФаза 3
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
Се регрутираФаза 2
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Се регрутираФаза 3
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
The Vanguard Study: Testing a New Way to Screen for Cancer
Се регрутираДобредојдени се здрави волонтери
- Walter Reed National Military Medical Center, Bethesda · на 7 милји
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Се регрутираФаза 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Се регрутираФаза 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Се регрутираНабљудувачка студија
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · на 7 милји
Collection of Blood From Patients With Prostate Cancer
Се регрутираНабљудувачка студија
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
Се регрутираНабљудувачка студија
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Collection of Blood From Patients With Cancer
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Precision-Based Genomics in Prostate Cancer
Се регрутираНабљудувачка студија
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
Се регрутираНабљудувачка студија
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
Се регрутираНабљудувачка студија
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
Се регрутираФаза 2
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
Се регрутираФаза 2
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Се регрутираФаза 2
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Се регрутираФаза 3
- George Washington University Medical Center, Washington D.C.
- UM Capital Region Medical Center, Largo · на 11 милји
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
Се регрутираНабљудувачка студија
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
Се регрутираФаза 2
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Men at High Genetic Risk for Prostate Cancer
Се регрутираНабљудувачка студија
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
Се регрутираФаза 1/2
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
Се регрутира
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
Се регрутираФаза 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Се регрутираФаза 3
- Sibley Memorial Hospital, Washington D.C.
- Suburban Hospital, Bethesda · на 7 милји
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Се регрутираФаза 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
Се регрутираФаза 2
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Се регрутираФаза 3
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Се регрутираФаза 1
- Maryland Oncology Hematology, Silver Spring · на 7 милји
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- National Institutes of Health Clinical Center, Bethesda · на 7 милји
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Се регрутираФаза 4
- VA Medical Center, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
- Cancer Support Community Research & Training Institute, Washington D.C.
Clinical Trial of Approaches to Prostate Cancer Surgery
Се регрутира
- Georgetown University, Washington D.C.
Castrate Resistant Prostate Cancer Enhertu Therapy
Се регрутираФаза 2
- Washington DC VAMC, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Се регрутираФаза 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
Се регрутираДобредојдени се здрави волонтери
- Howard University Hospital, Washington D.C.
- National Cancer Institute, Bethesda · на 7 милји
- Walter Reed National Military Medical Center, Bethesda · на 7 милји
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Се регрутираНабљудувачка студија
- Massive Bio SYNERGY-AI site, Silver Spring · на 7 милји
- Massive Bio SYNERGY-AI site, Bethesda · на 7 милји
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Се регрутираФаза 3
- George Washington University Medical Center, Washington D.C.
Испитувања за Рак на простата во други градови
- New York City, NY102 студии
- Houston, TX75 студии
- Los Angeles, CA60 студии
- Boston, MA59 студии
- St. Louis, MO46 студии
- San Francisco, CA45 студии
- Chicago, IL45 студии
- Philadelphia, PA44 студии
- Baltimore, MD43 студии
- Nashville, TN43 студии
- Seattle, WA42 студии
- Dallas, TX36 студии
Други студии во Washington
- Рак (сите типови)58 студии
- Рак на бели дробови со не-мали клетки55 студии
- Рак на дојка46 студии
- Метастатски карцином43 студии
- Рак на бели дробови41 студија
- Дебелина33 студии
- Колоректален карцином29 студии
- Кардиоваскуларни болести28 студии
- Рак на бешиката26 студии
- Акутна миелоидна леукемија24 студии
- Лимфом23 студии
- Карцином на јајниците23 студии
Од ClinicalTrials.gov, податоци преземени 7.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.